Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course London 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course London 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA

Home » ISOPP

ISOPP

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 12/10/20 by Xabier Antón Méndez

Analysis of the effectiveness of a chemotherapy extravasation protocol in a tertiary care hospital

Abstracts

View resources
Last reviewed: 27/04/20 by Paulina Billings

Analysis of the systemic anti-cancer therapy (SACT) returns pathway in chemotherapy preparation and dispensing unit (CPDU) to reduce waste and optimise efficiency

View resources
Last reviewed: 08/01/21 by Gamze Korubük

Analyzing the causes of disposal of the prepared chemotherapy drugs

Abstracts

View resources
Last reviewed: 27/04/20 by Esin Aysel Kandemir

Attitudes of medical oncologists on the treatment of cancer-associated venous thromboembolism

View resources
Last reviewed: 17/03/21 by James Clark

Bring care closer to home? Service users’ perceptions of receiving injection treatment in hospital, community and at home

Abstracts

View resources
Last reviewed: 18/03/21 by Antoine Sedrak

Cancer patient perspectives on community pharmacy diabetes screening service – a qualitative study of enablers and barriers

Abstracts

View resources
Last reviewed: 27/04/20 by Nikhil Tanna

Checkmate 384: phase 3b/4 trial of Nivolumab 480 mg Q4W vs 240 mg Q2W after ≤12 months of Nivolumab in previously treated advanced NSCLC

View resources
Last reviewed: 27/04/20 by Asli Ozyildirim

Chemotherapy-induced nausea and vomiting management in terms of compliance with national comprehensive cancer network guideline

View resources
Last reviewed: 27/04/20 by Helen Flint

Clinical audit on the use of fulvestrant in advanced breast cancer patients

View resources
Last reviewed: 27/04/20 by Takahiro Ohta

Clinical utility of the press through pack seal-type adherence support tool for locally advanced rectal cancer patients receiving capecitabine-based chemoradiotherapy

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 … 12 13
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Latest Conference 2026
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2026 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.